Whalegun
Home

Alnylam Pharmaceuticals ALNY paid The McManus Group $60K for lobbying in Q1 2023 · Medicare

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q1 2023
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
23/04/20

Up 20.0% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Alnylam Pharmaceuticals's other lobbying reports